Comparison of the Pharmacodynamics and Pharmacokinetics of Biphasic Insulin Aspart 50 to Biphasic Insulin Aspart 70 in Non-Obese and Obese With Type 2 Diabetes Mellitus
Phase of Trial: Phase III
Latest Information Update: 08 Jan 2017
At a glance
- Drugs Insulin aspart/insulin protamine aspart (Primary)
- Indications Type 2 diabetes mellitus
- Focus Pharmacokinetics
- Sponsors Novo Nordisk
- 15 May 2009 Actual patient number (75) added as reported by ClinicalTrials.gov.
- 15 May 2009 Actual end date (Jun 2004) added as reported by ClinicalTrials.gov.
- 25 Feb 2008 New trial record.